Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.

The National Highways Authority of India (NHAi) constructed 5,614 kilometres of national highways in the last financial year that ended on March 31, With this, NHAI claims to have exceeded its own ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

The complete response (CR) rate to the combination of the interleukin (IL)-15 superagonist nogapendekin alfa inbakicept-pmln (Anktiva®) and bacillus Calmette-Guerin (BCG) in BCG-unresponsive ...